Aug. 23, 2022 CDC recommends Novavax COVID-19 vaccine for adolescents Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo that Novavax’s COVID-19 vaccine be used as another primary series option for adolescents ages 12 through 17.
July 20, 2022 Air Force prepares for newly approved COVID-19 vaccine: Novavax provides new option for unvaccinated Airmen, Guardians The Air Force will soon have the Novavax COVID-19 vaccine available after the U.S Food and Drug Administration authorized it for emergency use and the Centers for Disease Control and Prevention endorsed it as another primary series option for adults ages 18 years and older.
Oct. 29, 2021 FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in children 5 through 11 years of age Today, the U.S. Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age. The authorization was based on the FDA’s thorough and transparent evaluation of the data that included input
March 1, 2021 FDA issues emergency use authorization for third COVID-19 vaccine Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be
Feb. 9, 2021 KMC volunteers help distribute COVID-19 vaccine The 86th Medical Group fielded a number of volunteers from the Kaiserslautern Military Community to assist in distributing COVID-19 vaccines to the surrounding areas.
Feb. 2, 2021 DOD experts explain: The science behind the COVID-19 vaccines Almost six weeks after the Food and Drug Administration issued emergency use authorization for the first two COVID-19 vaccines, many questions have arisen concerning their efficacy in attacking the SARS-CoV-2 virus and deadly COVID-19 disease.To better understand how COVID-19 vaccines work, MHS
Jan. 29, 2021 DOD personnel must do more to win fight against COVID-19, Special Advisor says While the personnel of the Defense Department have already done incredible work to combat the coronavirus, they must do more, Max Rose, a special advisor on COVID-19 to the defense secretary, said.
Jan. 27, 2021 DOD vaccinating personnel worldwide against COVID-19 A little more than a month after the Food and Drug Administration issued emergency use authorization for the Pfizer-BioNTech and Moderna COVID-19 vaccines Dec. 12 and Dec. 17, respectively, vaccines have been increasingly and successfully distributed and administered to Department of Defense
Dec. 11, 2020 Pro rata vaccine distribution is fair, equitable While COVID-19 vaccines roll out in limited supply, distribution is determined in direct proportion to the nation's adult population 18 years and older.
Dec. 10, 2020 DOD announces COVID-19 vaccine distribution plan Today, the Department of Defense announced its deliberate and phased plan to distribute and administer initial and subsequent allocations of the COVID-19 vaccine.
Dec. 1, 2020 COVID-19 Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna Inc.
Nov. 19, 2020 Road to COVID-19 vaccine is fast, safe Going fast doesn’t mean going dangerous.With recent reports that show Pfizer and Moderna vaccine candidates are more than 90% effective, Operation Warp Speed’s Chief Science Advisor Dr. Moncef Slaoui compared the rapid search for a vaccine to driving a racecar.
Nov. 19, 2020 SAMHS accepting volunteers for COVID-19 vaccine trial A kick-off event to commemorate the San Antonio Military Health System beginning Phase 3 of the AstraZeneca vaccine trial as part of Operation Warp Speed was held Nov. 18, 2020, at Brooke Army Medical Center, Joint Base San Antonio-Fort Sam Houston, Texas.
Nov. 17, 2020 Military Health System participating in COVID-19 vaccine trial Five military medical treatment facilities in the National Capital Region, Texas, and California are participating in a phase 3 clinical trial testing the AstraZeneca COVID-19 vaccine in development under Operation Warp Speed. The DoD sites are actively enrolling study participants, with a goal to
Nov. 17, 2020 An AFMS look at Operation Warp Speed Take a peak inside Operation Warp Speed headquarters in Washington D.C. Operation Warp Speed is an effort by several U.S. government components and public partnerships to facilitate the development, manufacturing and distribution of COVID-19 vaccines, therapeutics and diagnostics.
Oct. 28, 2020 I'm the FDA point person on COVID-19 vaccines. We'll make sure they're safe and effective. This Op-Ed by the U.S. Food & Drug Administration was originally published in USA Today. Placement of this Op-Ed does not imply promotion, nor unofficial or official endorsement, by the United States Air Force Office of the Air Force Surgeon General.